Drug Policy Publications Featured

Beckley Foundation releases ‘Roadmaps to Reforming the UN Drug Conventions’

December 31, 2012 BF drug policy publications - Intro

The new Beckley Foundation Report ‘Roadmaps to Reforming the UN Drug Conventions’ shows how the current prohibitionist Conventions could be amended to allow a country, or a group of countries, to experiment with adopting drug policies better suited to their own special needs.

Continue Reading →

Extended Summary

December 14, 2010 BF drug policy publications - Intro

Cannabis Policy: Moving Beyond Stalemate Extended Summary Prepared for UNGASS Vienna-March-2009 To download click here “That which is prohibited cannot easily be regulated” Cannabis came under the control of the international narcotics treaties as an afterthought, in an era when use of the drug was confined to relatively small groups in a scattering of cultures. […]

Continue Reading →

From Coercion to Cohesion

November 10, 2010 Drug Policy Library

Treating Drug Dependence Through Healthcare, Not Punishment Discussion paper based on a scientific workshop UNODC, Vienna October 28-30, 2009- Draft published 2 March 2010 The aim of this draft discussion paper, “From coercion to cohesion: Treating drug dependence through healthcare, not punishment”, is to promote a health-oriented approach to drug dependence. The International Drug Control Conventions […]

Continue Reading →
Thumbnail image for The Effects of Decriminalisation of Drug Use in Portugal

The Effects of Decriminalisation of Drug Use in Portugal

September 22, 2010 BF drug policy publications

In 2004, the Beckley Foundation reported on the legal changes that took place in Portugal in 2001 (Allen, Trace & Klein 2004). This report aims to provide an updated overview of the effects of these changes, using data from the evaluations that have been carried out and from new interviews with key stakeholders in Portugal. […]

Continue Reading →

Drug Use: Knowledge, Culture and Context

September 22, 2010 BF drug policy publications

The topic of data and its strength, range and validity has acquired considerable prominence in recent debates taking place around the conduct of international drug policy. There has been a growing movement for “evidence-based policy” in health policy more broadly, and this has permeated drug policy as part of a gradual, but general, shift in […]

Continue Reading →